Until now, ovarian cancer has been a difficult disease to diagnose at early stages. A new screening test is now in development that can detect ovarian cancer with 90% accuracy. Early diagnosis leads to much better treatment outcomes.
A screening test with a 90 per cent accuracy rate for detecting potentially fatal ovarian cancer early is a major step closer.
Studying blood serum compounds led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer. Early diagnosis is vital for treatment of ovarian cancer.
Researchers, using liquid chromatography and mass spectrometry techniques coupled with machine learning computer algorithms, have identified 16 metabolite compounds that provided unprecedented accuracy in distinguishing 46 women with early-stage ovarian cancer from a control group of 49 women who did not have the disease.
Blood samples for the study were collected from Canada and the United States, but the researchers – whose findings were published in the journal Scientific Reports – say more extensive testing across a larger population will be needed to determine if the high diagnostic accuracy will be maintained across a larger group of women.
Read Full Article: Blood test detects ovarian cancer in nine out of 10 patients – Telegraph